Cargando…

Software to predict the right dose for vancomycin in a clinical environment—A commentary on: Personalised dosing of vancomycin: A prospective and retrospective comparative quasi‐experimental study by Luqman Vali et al.

Detalles Bibliográficos
Autores principales: Dijkstra, Jacob A., Veldkamp, Agnes I., Sieswerda, Elske, van Agtmael, Michiel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451928/
https://www.ncbi.nlm.nih.gov/pubmed/33638868
http://dx.doi.org/10.1111/bcp.14765
_version_ 1784569958101942272
author Dijkstra, Jacob A.
Veldkamp, Agnes I.
Sieswerda, Elske
van Agtmael, Michiel
author_facet Dijkstra, Jacob A.
Veldkamp, Agnes I.
Sieswerda, Elske
van Agtmael, Michiel
author_sort Dijkstra, Jacob A.
collection PubMed
description
format Online
Article
Text
id pubmed-8451928
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-84519282021-09-27 Software to predict the right dose for vancomycin in a clinical environment—A commentary on: Personalised dosing of vancomycin: A prospective and retrospective comparative quasi‐experimental study by Luqman Vali et al. Dijkstra, Jacob A. Veldkamp, Agnes I. Sieswerda, Elske van Agtmael, Michiel Br J Clin Pharmacol Commentaries John Wiley and Sons Inc. 2021-02-27 2021-09 /pmc/articles/PMC8451928/ /pubmed/33638868 http://dx.doi.org/10.1111/bcp.14765 Text en © 2021 The Authors. British Journal of Clinical Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Commentaries
Dijkstra, Jacob A.
Veldkamp, Agnes I.
Sieswerda, Elske
van Agtmael, Michiel
Software to predict the right dose for vancomycin in a clinical environment—A commentary on: Personalised dosing of vancomycin: A prospective and retrospective comparative quasi‐experimental study by Luqman Vali et al.
title Software to predict the right dose for vancomycin in a clinical environment—A commentary on: Personalised dosing of vancomycin: A prospective and retrospective comparative quasi‐experimental study by Luqman Vali et al.
title_full Software to predict the right dose for vancomycin in a clinical environment—A commentary on: Personalised dosing of vancomycin: A prospective and retrospective comparative quasi‐experimental study by Luqman Vali et al.
title_fullStr Software to predict the right dose for vancomycin in a clinical environment—A commentary on: Personalised dosing of vancomycin: A prospective and retrospective comparative quasi‐experimental study by Luqman Vali et al.
title_full_unstemmed Software to predict the right dose for vancomycin in a clinical environment—A commentary on: Personalised dosing of vancomycin: A prospective and retrospective comparative quasi‐experimental study by Luqman Vali et al.
title_short Software to predict the right dose for vancomycin in a clinical environment—A commentary on: Personalised dosing of vancomycin: A prospective and retrospective comparative quasi‐experimental study by Luqman Vali et al.
title_sort software to predict the right dose for vancomycin in a clinical environment—a commentary on: personalised dosing of vancomycin: a prospective and retrospective comparative quasi‐experimental study by luqman vali et al.
topic Commentaries
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451928/
https://www.ncbi.nlm.nih.gov/pubmed/33638868
http://dx.doi.org/10.1111/bcp.14765
work_keys_str_mv AT dijkstrajacoba softwaretopredicttherightdoseforvancomycininaclinicalenvironmentacommentaryonpersonaliseddosingofvancomycinaprospectiveandretrospectivecomparativequasiexperimentalstudybyluqmanvalietal
AT veldkampagnesi softwaretopredicttherightdoseforvancomycininaclinicalenvironmentacommentaryonpersonaliseddosingofvancomycinaprospectiveandretrospectivecomparativequasiexperimentalstudybyluqmanvalietal
AT sieswerdaelske softwaretopredicttherightdoseforvancomycininaclinicalenvironmentacommentaryonpersonaliseddosingofvancomycinaprospectiveandretrospectivecomparativequasiexperimentalstudybyluqmanvalietal
AT vanagtmaelmichiel softwaretopredicttherightdoseforvancomycininaclinicalenvironmentacommentaryonpersonaliseddosingofvancomycinaprospectiveandretrospectivecomparativequasiexperimentalstudybyluqmanvalietal